Finzati - Logo
ATTO logo

Attovia Therapeutics, Inc.

ATTO • Biotechnology
$14.04
▲ +0.15 (+1.08%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 43%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$604.14M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.03Healthy liquidity · 14.2Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Sep 4, 2026, 12:10 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$14.04
Change1.08%
Shares Out43.03M
Market Cap$604.14M
Enterprise Value$491.05M
52W Range16.15 - 26.07
Beta0.00
P/B5.36
Gross Margin40.44%
Oper. Margin-49.75%
Profit Margin-44.91%
Debt/Eq0.03

Investment DNA

How strong this company looks for long-term investors

27
out of 100
Business Quality
Margins, moat, returns
30/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
36/100
Why this score▼
Manageable debt level · 0.03Healthy liquidity · 14.2Weak profitability

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-09-04
Low
$39.00
Mean
$45.33
Median
$45.00
High
$52.00

Company Overview

IPO: 8/5/2026
Industry: Biotechnology
P/B i: 5.36
Debt / Equity i: 0.03
Operating Margin: -4974.74%
Net Margin: -4490.89%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.03
Current Ratio: 14.20
Quick Ratio: 14.20
Status: Good

Insider Transactions

Recent executive and insider activity

⚠ 10 high-volume insider sells detected
GOLDMAN SACHS GROUP INC
Transaction: 08/05/2026
BUY
Change
+2,872
Price
Not reported
Filing
08/28/2026
Type
BUY
WALSH COLIN
Transaction: 08/05/2026
BUY
Change
+2,872
Price
Not reported
Filing
08/28/2026
Type
BUY
GOLDMAN SACHS GROUP INC
Transaction: 08/06/2026
SELL
Change
-4,445,275
Price
Not reported
Filing
08/13/2026
Type
SELL